Avrobio Inc (AVRO)
16.80
-0.24
(-1.41%)
USD |
NASDAQ |
Jun 20, 16:00
1.39
-15.41
(-91.73%)
Pre-Market: 20:00
Avrobio Cash and Short Term Investments (Quarterly): 90.48M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 90.48M |
| December 31, 2023 | 98.02M |
| September 30, 2023 | 105.84M |
| June 30, 2023 | 124.69M |
| March 31, 2023 | 72.33M |
| December 31, 2022 | 92.56M |
| September 30, 2022 | 115.97M |
| June 30, 2022 | 132.41M |
| March 31, 2022 | 161.66M |
| December 31, 2021 | 189.57M |
| September 30, 2021 | 201.37M |
| June 30, 2021 | 226.44M |
| March 31, 2021 | 233.03M |
| Date | Value |
|---|---|
| December 31, 2020 | 259.68M |
| September 30, 2020 | 219.55M |
| June 30, 2020 | 244.38M |
| March 31, 2020 | 257.70M |
| December 31, 2019 | 187.04M |
| September 30, 2019 | 206.36M |
| June 30, 2019 | 90.35M |
| March 31, 2019 | 108.48M |
| December 31, 2018 | 126.30M |
| September 30, 2018 | 138.58M |
| June 30, 2018 | 155.02M |
| March 31, 2018 | 57.93M |
| December 31, 2017 | 5.963M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
72.33M
Minimum
Mar 2023
259.68M
Maximum
Dec 2020
165.47M
Average
174.35M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Agenus Inc | 52.86M |
| BioCryst Pharmaceuticals Inc | 336.55M |
| AIM ImmunoTech Inc | 10.94M |
| Protalix BioTherapeutics Inc | 48.49M |
| Armata Pharmaceuticals Inc | 37.86M |